Molecular Mechanisms Underlying the Reabsorption of Inorganic Phosphate in Renal Tubules
Molecular Mechanisms Underlying the Reabsorption of Inorganic Phosphate in Renal Tubules
批准号:
16590809
负责人:
MICHIGAMI Toshimi
金额:
$1.92万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Megalin is a multifunctional endocytic receptor expressed in renal proximal tubules, and plays critical roles in the renal uptake of various proteins. We hypothesized that megalin-dependent endocytosis might play a role in renal reabsorption of inorganic phosphate. To address the short-term effects of altered megalin function, we administered a recombinant protein for the soluble form of 39-kD receptor associated protein (RAP) intraperitoneally to 7-wk-old mice. The recombinant protein was prepared as histidine-tagged soluble RAP (aa 39-356) lacking the amino-terminal signal peptide and the carboxyl terminal endoplasmic reticulum (ER) retention signal, which was designated as His-sRAP. After the direct interaction between His-sRAP and megalin was confirmed, mice were given a single intraperitoneal injection of His-sRAP (3.5 mg/dose). Immunostaining and Western blot analyses demonstrated that the uptake of His-sHAP and the accelerated internalization of megalin in proximal tubular cells 1 hour after administration. Interestingly, internalization of the type II sodium/phosphate co-transporter (NaPi-II) was observed. Three sequential administrations of His-sRAP (3.5 mg/dose, three doses with 4-hr intervals) increased the urinary excretion of low molecular weight proteins including vitamin D-binding protein. In addition, the urinary excretion of phosphate was also increased, and the protein level of NaPi-II in the brush border was decreased. Serum 25-hydroxyvitamin D was decreased, while the plasma level of intact parathyroid hormone was not altered. These results suggest that the His-sRAP induced acceleration of megalin-mediated endocytosis caused phosphaturia via altered subcellular distribution of NaPi-II.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1074/jbc.m509347200
发表时间:
2005-12-09
期刊:
JOURNAL OF BIOLOGICAL CHEMISTRY
影响因子:
4.8
作者:
[Miyauchi, Y, Michigami, T, Ozono, K]
通讯作者:
Ozono, K
DOI:
10.1681/asn.2004070599
发表时间:
2005-08-01
期刊:
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
影响因子:
13.6
作者:
[Yamagata, M, Ozono, K, Michigami, T]
通讯作者:
Michigami, T
Intraperitoneal administration of recombinant receptor-associated protein causes phosphaturia via an alteration in subcellular distribution of the renal sodium
腹腔内给予重组受体相关蛋白通过改变肾钠的亚细胞分布引起磷酸尿
DOI:
--
发表时间:
2005
期刊:
Journal of American Society of Nephrology 16・8
影响因子:
--
作者:
[Yamagata M, Ozono K, Hashimoto Y, Miyauchi Y, Kondou H, Michigami T]
通讯作者:
Michigami T
Intraperitoneal administration of recombinant receptor-associated protein cause phosphaturia via an alteration in subcellular distribution of the renal sodium phosphate co-transporter.
腹腔内给予重组受体相关蛋白通过改变肾脏磷酸钠协同转运蛋白的亚细胞分布引起磷酸尿。
DOI:
--
发表时间:
2005
期刊:
Journal of American Society of Nephrology 16・8
影响因子:
--
作者:
[Yamagata M, Ozono K, Hashimoto Y, Miyauchi Y, Kondou H, Michigami T.]
通讯作者:
Michigami T.
Examination of megalin in renal tubular epithelium from patients with Dent disease.
检查 Dent 病患者肾小管上皮中的巨蛋白。
DOI:
--
发表时间:
2004
期刊:
Pediatr Nephrol 19
影响因子:
--
作者:
[Santo Y, Hirai H, Shima M, Yamagata M, Michigami T, Nakajima S, Ozono K.]
通讯作者:
Ozono K.
Molecular Mechanism for Phosphate Sensing and Bone-Kidney Functional Interaction
-
批准号:23591227
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.33万
-
财政年份:2011
-
负责人:MICHIGAMI Toshimi
-
依托单位:
Mechanism Underlying the Responsiveness to the Extracellular Phosphate and the Factors which Influence the Sensitivity to FGF23
-
批准号:20590986
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2008
-
负责人:MICHIGAMI Toshimi
-
依托单位:
Functional Relationship between the Molecules Involved in the Renal Phosphate Reabsorption
-
批准号:18590921
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.45万
-
财政年份:2006
-
负责人:MICHIGAMI Toshimi
-
依托单位:
Development of Organ-specific Treatment for Bone Metastasis in Neuroblastoma
-
批准号:14570793
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.86万
-
财政年份:2002
-
负责人:MICHIGAMI Toshimi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
CapZβ在早期内体成熟中的功能及分子机制研究
-
批准号:32070702
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:岳剑波
-
依托单位:
活细胞高分辨率成像解析clathrin介导的内吞囊泡形成早期内体的分子机制
-
批准号:31970659
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2019
-
负责人:何康敏
-
依托单位:
Vici综合症蛋白EPG5协同调控内吞运输和自噬通路的机制研究
-
批准号:31871426
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2018
-
负责人:王峥
-
依托单位:
NRT1.1磷酸化修饰调控植物侧根发育的分子细胞学机制研究
-
批准号:31871424
-
项目类别:面上项目
-
资助金额:59.0万元
-
批准年份:2018
-
负责人:单晓昳
-
依托单位:
生长素调控植物细胞网格蛋白质膜招募的分子机理研究
-
批准号:31801193
-
项目类别:青年科学基金项目
-
资助金额:27.0万元
-
批准年份:2018
-
负责人:王超
-
依托单位:
核酸适体RCC-H1b对肾癌识别和细胞核定位的研究
-
批准号:31701249
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2017
-
负责人:胡小晓
-
依托单位:
Tom1L1在胞内体蛋白分选机制中功能的研究
-
批准号:31171289
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2011
-
负责人:刘宁生
-
依托单位:
钙离子不依赖电压依赖型分泌及其内吞的分子机制研究
-
批准号:30970660
-
项目类别:面上项目
-
资助金额:32.0万元
-
批准年份:2009
-
负责人:张曦
-
依托单位:
IgA Fc受体(FcalphaR)内吞和脱落机制的研究
-
批准号:30872287
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2008
-
负责人:张伟
-
依托单位: